Phosphate binding gels: balancing phosphate adsorption and aluminum toxicity

Area of Science:

• Pharmacology
• Biochemistry
• Materials Science

Background:

• Phosphate binders are crucial for managing hyperphosphatemia in patients with chronic kidney disease.
• Aluminum hydroxide has historically been used as a phosphate binder but carries a risk of aluminum toxicity.
• Developing effective and safe phosphate binders remains a clinical challenge.

Purpose of the Study:

• To assess the in vitro phosphate binding capacity of commercial aluminum hydroxide phosphate binders.
• To evaluate the potential for aluminum toxicity by measuring soluble aluminum species formation.
• To identify characteristics of an ideal phosphate binder.

Main Methods:

• An in vitro procedure simulated gastrointestinal transit from stomach to small intestine.
• Phosphate binding capacity was quantified for five commercial gels and two crystalline aluminum hydroxide forms.
• Soluble aluminum species were determined by acid neutralization at pH 3 and 37°C.

Main Results:

• Significant variability was observed in both phosphate binding capacity and soluble aluminum production among commercial products.
• Some aluminum hydroxide formulations released substantial amounts of soluble aluminum under simulated gastric conditions.
• A trade-off exists between high phosphate binding and low aluminum solubility.

Conclusions:

• Commercial aluminum hydroxide phosphate binders exhibit diverse performance characteristics.
• Minimizing soluble aluminum formation during gastric transit is critical for reducing aluminum toxicity risk.
• The ideal phosphate binder requires a carefully balanced surface area for effective phosphate adsorption and safety.